Moxalactam is not more active on extended spectrum β-lactamase (ESBL) producing bacteria than on non-ESBL producers
Bhoj R Singh Division of Epidemiology, ICAR-Indian Veterinary Research Institute, Izatnagar, IndiaIn a recently published article1 moxalactam has been claimed to be very effective on extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae, concluding “MOX demons...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2018-03-01
|
| Seri Bilgileri: | Infection and Drug Resistance |
| Konular: | |
| Online Erişim: | https://www.dovepress.com/moxalactam-is-not-more-active-on-extended-spectrum-beta-lactamase-esbl-peer-reviewed-article-IDR |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|